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Article focus
  This study investigated the effects of 
intra-articular injection of local anaesthet-
ics (lA), glucocorticoids (GC), hyaluronic 
acid (HA), contrast agent (CA), and 
tranexamic acid (TA) on the viability of 
primary human chondrocytes and 
tenocytes.
Key messages
  Cytotoxicity of intra-articular injected 
drugs towards chondrocytes and teno-
cytes depends on the concentration of 
the drug.
  lA (lidocaine, bupivacaine) and triamci-
nolone acetonide had strong toxic effects 
on chondrocytes and tenocytes in low 
dilutions.
  Dexamethasone, TA, and CA had only 
minor effects on chondrocytes and teno-
cytes whereas HA did not affect cell 
viability.
Strengths and limitations
  Cytotoxicity of clinically relevant intra-
articular injectable drugs was compared. 
To our knowledge, no comparable study 
has been published.
  This study was performed in vitro, and cells 
were isolated from their extracellular 
matrix, therefore effects may be reduced in 
healthy intact cartilage and tendon tissue.
cytotoxicity of drugs injected  
into joints in orthopaedics
Objectives
Intra-articular injections of local anaesthetics (LA), glucocorticoids (Gc), or hyaluronic acid 
(HA) are used to treat osteoarthritis (oA). contrast agents (cA) are needed to prove success-
ful intra-articular injection or aspiration, or to visualize articular structures dynamically dur-
ing fluoroscopy. Tranexamic acid (TA) is used to control haemostasis and prevent excessive 
intra-articular bleeding. Despite their common usage, little is known about the cytotoxicity 
of common drugs injected into joints. Thus, the aim of our study was to investigate the 
effects of LA, Gc, HA, cA, and TA on the viability of primary human chondrocytes and teno-
cytes in vitro.
Methods
Human chondrocytes and tenocytes were cultured in a medium with three different drug 
dilutions (1:2; 1:10; 1:100). The following drugs were used to investigate cytotoxicity: 
lidocaine hydrochloride 1%; bupivacaine 0.5%; triamcinolone acetonide; dexamethasone 
21-palmitate; TA; iodine contrast media; HA; and distilled water. normal saline served as a 
control. After an incubation period of 24 hours, cell numbers and morphology were assessed.
Results
Using LA or Gc, especially triamcinolone acetonide, a dilution of 1:100 resulted in only a 
moderate reduction of viability, while a dilution of 1:10 showed significantly fewer cell 
counts. TA and cA reduced viability significantly at a dilution of 1:2. Higher dilutions did 
not affect viability. notably, HA showed no effects of cytotoxicity in all drug dilutions.
Conclusion
The toxicity of common intra-articular injectable drugs, assessed by cell viability, is mainly 
dependent on the dilution of the drug being tested. LA are particularly toxic, whereas HA 
did not affect cell viability.
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introduction
The intra-articular injection of medication is common in 
orthopaedics. Most of these drugs such as local anaes-
thetics (lA), glucocorticoids (GC), or hyaluronic acid (HA) 
are used to treat osteoarthritis (oA). It is estimated that 
10% of the world’s population who are 60 years or older 
have significant clinical problems that can be attributed 
to oA.1 The use of intra-articular injections for the 
 management of oA is increasing.2 An epidemiological 
analysis of non-operative interventions used in patients 
with knee oA in the United States in 2009 revealed that, 
during the previous five years, 43.5% of the patients who 
underwent total knee arthroplasty (TKA) were preopera-
tively treated with intra-articular GC injection and 15.4% 
of patients received viscosupplementation injections 
such as HA.3
Despite their common usage, little is known about the 
cytotoxicity of common drugs administered into the 
joint. The aim of our study was to investigate the effects 
of lA, GC, HA, contrast agents (CA), and tranexamic acid 
(TA) on the viability of primary human chondrocytes and 
tenocytes in vitro.
Materials and Methods
The study design was approved by the Institutional 
Review Board (protocol number EK 33022017). The fol-
lowing drugs (Table I) were used to investigate their 
cytotoxity on human chondrocytes and tenocytes: lido-
caine hydrochloride 1% (Xylocitin-loc 1%; mibe GmbH, 
Brehna, Germany); bupivacaine 0.5% (Carbostesin; 
AstraZeneca GmbH, Wedel, Germany); triamcinolone 
acetonide (40 mg, TriamHEXAl; HEXAl AG, Holzkirchen, 
Germany), dexamethasone 21-palmitate (2.5 mg dexa-
methasone, lipotalon; Recordati Pharma GmbH, Ulm, 
Germany); tranexamic acid (500 mg/5 ml, Cyklokapron-
Injektionslösung; Pfizer Pharma PFE GmbH, Berlin, 
Germany); iodine contrast media (300 mg iodine/ml, 
Solutrast; Bracco Imaging Deutschland GmbH, Konstanz, 
Germany); hyaluronic acid (1% hyaluronic acid in physi-
ologic saline); and distilled water. Normal saline (NS) 
served as a control. Chondrocytes and tenocytes were 
cultured in a medium with three different drug dilutions 
(1:2, 1:10, and 1:100). The experiments were performed 
using cells from three different donors.
isolation of human chondrocytes and tenocytes. Human 
cartilage from normal areas was harvested from three 
healthy donors aged 58 and 74 years (both male) and 
59 years (female) undergoing TKA after obtaining their 
informed consent. on the same day, cartilage samples 
were cut into small pieces, transferred into six-well cell 
culture plates and treated with collagenase II (0.2% in 
Dulbecco’s Modified Eagle Medium (DMEM)) for 24 
hours at 37°C. After filtration through a 70 µm filter, the 
solution was centrifuged (five minutes at 1500 rpm), the 
supernatant was discarded, the remaining cell pellet was 
resuspended in growth medium (DMEM, 15% FCS, 1% 
penicillin/streptomycin), and cells were seeded into cell 
culture flasks and incubated at 37°C and 5% Co2. After 
seven days, the medium was changed for the first time 
and cells were cultured until confluency with the subse-
quent medium changed every two to three days.
A segment of tendon of the proximal long head of 
biceps was harvested from three healthy donors aged 51 
and 59 years (both male) and 61 years (female) undergo-
ing shoulder arthroscopy and biceps tenodesis. The isola-
tion of tenocytes was undertaken as described for the 
chondrocytes in this study except for the use of colla-
genase solution; to digest the tendon, collagenase I 
(0.2% in DMEM) was used.
investigation of cytotoxicity. Human chondrocytes or 
tenocytes of the three donors were seeded at 2*104 cells/
cm2 and incubated for 24 hours in a growth medium to 
ensure sufficient cell adhesion. After that, the medium 
was changed to a growth medium containing the par-
ticular drug dilution. Following a 24-hour incubation 
period, cells were washed with phosphate-buffered 
saline (PBS), stained for viability analysis, fixed with 4% 
neutral buffered formaldehyde for histological analysis or 
frozen at -80°C until biochemical analysis.
Biochemical analysis of cell number. For biochemical 
determination of cell number, frozen samples were 
thawed, and cells were lysed in PBS containing 1% 
Triton X-100 (Sigma-Aldrich Corp., St. louis, Missouri) 
for 30 minutes on ice at room temperature. The activ-
ity of lactate dehydrogenase (lDH) was quantified using 
the CytoTox 96® Non-Radioactive Cytotoxicity Assay 
(Promega Corp., Madison, Wisonsin) according to the 
manufacturer’s instructions, and correlated with the cell 
numbers using a calibration line. The experiments were 
performed in triplicate.
Statistical analysis. Numerical data were statistically ana-
lyzed using GraphPad Prism 5.04 software (GraphPad 
Software Inc., la Jolla, California). All values are 
expressed as mean and sd. Statistical analysis was per-
formed on quantified data using one-way analysis of 
variance (ANovA). For post hoc testing, two tailed non-
paired t-tests where NS served as negative control, were 
performed. Differences were considered significant when 
p < 0.05.
histological analysis. For staining with haematoxylin 
and eosin (H&E), fixed cells were washed with PBS and 
incubated for three minutes with haematoxylin (Merck 
KGaA, Darmstadt, Germany). Then the slides were 
washed again with PBS and incubated for another three 
minutes with eosin (Merck). Finally, cells were washed 
with distilled water and examined using a light micro-
scope (Keyence BZ 9000; Keyence Germany GmbH, Neu-
Isenburg, Germany).
Live cell staining. Immediately after washing with PBS, live 
cells were stained with 2.4 µM calcein (Invitrogen, Thermo 
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Fisher Scientific, Waltham, Massachusetts) in PBS and incu-
bated for 30 minutes at 37°C in the dark. After that, the 
staining solution was substituted by PBS. Images were 
taken with the fluorescence microscope Keyence BZ 9000.
Results
Cell numbers, after culturing chondrocytes and teno-
cytes at different dilutions of the investigated drugs, are 
presented in Figures 1 and 2, respectively.
Compared with NS at a dilution of 1:2 lA (lidocaine, 
bupivacaine), as well as triamcinolone acetonide, TA and 
iodine contrast media showed strong cytotoxic effects 
towards chondrocytes and tenocytes as determined by 
significantly reduced cell numbers. For dexamethasone, 
a significantly lower number of cells was detected only 
for chondrocytes in dilution 1:2. HA did not affect cell 
numbers of both types in each dilution. For chondro-
cytes, additionally, cell numbers were also decreased 
when cultured with GC at a dilution of 1:10 and with lA 
at a dilution of 1:10 and 1:100. Culturing tenocytes with 
lA and triamcinolone acetonide at a dilution of 1:10 also 
resulted in significantly reduced cell numbers. At a dilu-
tion of 1:100, none of the investigated drugs showed any 
cytotoxic effects.
Staining with H&E (Figs 3 and 4) showed that cell mor-
phology changed, and cell growth was reduced for both 
cell types after culturing cells with lidocaine and bupiv-
acaine in dilution 1:2 and 1:10. Morphology of chondro-
cytes changed from a spindle-like phenotype to narrowed 
rounded cells while tenocytes had lost their typical 
 spindle-shaped appearance and converted to a polygonal 
shape. For chondrocytes, toxic effects are also visible for 
triamcinolone acetonide, TA and iodine contrast media in 
dilution 1:2, whereas tenocytes showed reactions only for 
triamcinolone acetonide and TA in dilution 1:2.
live staining (Figs 5 and 6) of chondrocytes and teno-
cytes has shown that, for both types of cells, culturing 
with lidocaine and bupivacaine in dilution 1:2 and 1:10 
and culturing with triamcinolone acetonide in dilution 
1:2 resulted in a reduction of visible living cells.
Discussion
We found that toxicity of common intra-articular injecta-
ble drugs, assessed by cell viability, is mainly dependent 
on the dilution of the drug being tested. Drug-incubated 
chondrocytes and tenocytes showed comparable viabil-
ity values.
The intra-articular injection of lA, including lidocaine 
and bupivacaine has been commonly used for the evalu-
ation of atypical pain and is generally accepted as safe.4 
Glucocorticoids are known as potent anti-inflammatory 
agents that act through a variety of mechanisms on dif-
ferent cellular levels.12 However, GC and lA may induce 
apoptosis in chondrocytes13 and should therefore be 
used with caution, especially in joints with compromised 
cartilage.14 our investigations showed that lA at a dilu-
tion of 1:100 resulted in only moderate reduction of cell 
viability whereas a dilution of 1:10 and 1:2 led to a high 
cytotoxicity. our results have demonstrated that the 
cytotoxic effect of lA is dose-dependent. Karpie and 
Chu15 also found a dose- and time-dependent cytotoxic 
effect of lidocaine on bovine articular chondrocytes. 
Moreover, they had pointed out that an intact articular 
surface was not protective for lidocaine. In contrast, the 
table i. Description of investigated drugs
Drug Class of drug Scope of application/effect/mode of action
lidocaine local anaesthetic 1) Temporary amelioration of pain.4
2)  Intra-articular use for reduction of anterior shoulder dislocations should be strongly considered as a 
first-line therapy.5
Bupivacaine local anaesthetic 1) Use in arthroscopic surgery.
2) Continuous intra-articular infusions for analgesia after shoulder surgery.6
Triamcinolone acetonide Glucocorticoid 1) A class of steroid hormones that mediate many physiological effects in most vertebrates.
2) one of the most widely prescribed classes of drugs.
3)  Involved in many physiological processes including glucose homeostasis, development, metabolism, 
and programmed cell death.
4) Pharmacological benefits are primarily anti-inflammatory and immunosuppressive.7
Dexamethasone Glucocorticoid
Tranexamic acid (TA) Antifibrinolytic 
haemostatic
1)  Synthetic derivative of the amino acid lysine that exerts its antifibrinolytic effect through the 
reversible blockade of lysine binding sites on plasminogen molecules.8
2)  Is used to support haemostasis and prevent excessive intra-articular bleeding.
3)  Intravenous or intra-articular administration, whereas one single intra-articular dose and two 
intravenous doses of TA have equivalent efficacy and safety in management of blood loss at total 
knee arthroplasty.9
Iodine contrast media Contrast media 1)  Needed to prove successful intra-articular injection or aspiration, or to visualize articular structures 
dynamically during fluoroscopy.
2)  Contrast agents (CAs) that go beyond qualitative visualization and enable quantitative assessments 
of functional tissue performance represent the next generation of CA.
3)  one clinical area where CAs can have a significant impact is in the diagnosis of soft-tissue-based 
diseases such as osteoarthritis.10
Hyaluronic acid Cartilage-protective 1) High-molecular-weight polysaccharide.
2) Important component of synovial fluid and extracellular matrix of articular cartilage.
3) Contributes to the elasticity and viscosity of synovial fluid.
4)  Acts as a fluid shock absorber and helps to maintain the structural and functional characteristics of 
the cartilage matrix.11
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intact bovine articular surface has some chondroprotective 
effects for bupivacaine, which is cytotoxic to bovine articu-
lar chondrocytes after an exposure of 15 to 30 minutes.6 
We had similar dose-dependent findings when using GC. 
Triamcinolone acetonide, in particular, reduced cell viabil-
ity significantly at a dilution of 1:2 and 1:10. In a controlled 
in vivo study with rats, Sola et al16 found that, after one 
week, 4  mg/ml triamcinolone resulted in a lower chondro-
cyte viability as compared with 1 mg/ml triamcinolone. As 
triamcinolone is a depository drug with prolonged action, 
and works as an anti-inflammatory agent in controlling 
symptoms and providing a longer remission effect,17 it is 
widely used in clinical situations.
Several studies have demonstrated that there are differ-
ences between individual drugs of lA and GC. lidocaine 
and bupivacaine, in particular, have a dose-dependent 
effect on chondrocytes18,19 and tenocytes, whereas ropiv-
acaine does not show this effect.20 High concentrations of 
triamcinolone acetonide may cause irreversible effects in 
human tenocytes,17 while dexamethasone shows no effect 
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Fig. 1c
Cell numbers of chondrocytes after 24-hour incubation with different dilutions of the different drugs determined by lactate dehydrogenase (lDH) assay. a) 
Dilution 1:2, b) Dilution 1:10, c) Dilution 1:100. Results are presented as mean and sd for each drug. For all dilutions, one-way analysis of variance (ANovA) 
showed significant differences between the groups (p-value < 0.0001). For post hoc testing, * (p-value < 0.05), † (p-value < 0.01) and ‡ (p-value < 0.001) indicate 
statistical significance (non-paired t-test) towards normal saline.
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on viability on bovine tenocytes in culture.20 A recent 
review analyzing the infection rate following total hip 
arthroplasty found no evidence of an increased infection 
rate following a previous injection of the joint with GCs, 
however, the authors stated that the existing level of evi-
dence is low, and high-quality multi-centre randomized 
trials are needed.21
For TA and CA, reduced cell viability was only observed 
at a dilution of 1:2. Parker et al22 had shown in their in 
vitro investigations that there is a dose- dependent effect 
for TA on human articular chondrocytes. Additionally, 
they had transferred the results to clinical practice and 
concluded that a tissue concentration of 10 mg/ml to 20 
mg/ml of TA could be expected to be safe.22 In contrast, 
HA showed no toxicity at all in investigated dilutions. 
Experimental in vitro investigations have demonstrated 
that HA treatment may regulate different biochemical 
pathways involved during cartilage damage.23
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‡
†
‡
Cell numbers of tenocytes after 24-hour incubation with different dilutions of the different drugs determined by lDH assay. a) Dilution 1:2, b) Dilution 1:10, c) 
Dilution 1:100 Results are presented as mean and sd for each drug. While for dilutions 1:2 and 1:10, one-way ANovA showed significant differences between 
the groups (p-value < 0.0001), dilution 1:100 resulted in no significant difference (p-value = 0.4887). For post hoc testing, * (p-value < 0.05), † (p-value < 0.01) 
and ‡ (p-value < 0.001) indicate statistical significance (non-paired t-test) towards normal saline.
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The knee joint has about 5 to 9 mls of synovial fluid 
with a pH of 7 to 8. For intra-articular injection, usually 5 
ml to 10 ml of lA or 1 ml to 2 ml of GC are used. According 
to that, dilution of lA with native synovial fluid is approxi-
mately 1:2 and dilution of GC with native synovial fluid is 
approximately 1:10. Since there is some evidence that 
high concentrations of lA have toxic effects on chondro-
cytes and tenocytes, it might be wise to inject a lower 
concentration of lA or dilute it with saline or HA.
our study has some limitations. When comparing 
the in vitro results with clinical intra-articular injection, 
it should be remembered that, for our experiments, 
cells were isolated from their native extracellular matrix. 
As shown by Piper and Kim,24 the cytotoxicity of lA is 
less when using native cartilage with an intact extracel-
lular matrix. This suggests that the cytotoxicity for 
chondrocytes and tenocytes demonstrated in our study 
may be reduced in healthy intact cartilage and tendon. 
Moreover, the amount of time required by the drug for 
cellular exposure depends on various factors in humans, 
such as metabolism of the injected drugs or anatomic 
nature of the joint injected. To investigate further the 
effects of intra-articular injected drugs on cartilage and 
tendons in vivo, a small animal model would be sufficient 
as a next step; this would allow for histological analysis 
after a series of injections. Additionally, there are new oA 
protective therapies, like Torin 1. These will need to be 
assessed prior to clinical application and will also have to 
be compared with the clinically established drugs for 
intra-articular injection.25
In conclusion, we found that the cytotoxicity of intra-
articular injected drugs towards chondrocytes and 
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Fig. 4
Haematoxylin and eosin (H&E) staining of tenocytes. Cell nuclei are coloured 
blue/violet by haematoxylin. Cytoplasm is coloured red/pink by eosin. Nor-
mal saline serves as control.
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Fig. 3
Haematoxylin and eosin (H&E) staining of chondrocytes. Cell nuclei are 
coloured blue/violet by haematoxylin. Cytoplasm is coloured red/pink by 
eosin. Normal saline serves as control.
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tenocytes depends on the concentration of the drug. lA 
such as lidocaine and bupivacaine demonstrated the 
highest toxic effects of the drugs investigated. The indica-
tion for intra-articular injection should therefore be 
defined carefully. Also, GCs had toxic effects on chondro-
cytes and tenocytes with triamcinolone acetonide more 
than dexamethasone. TA had only minor effects on chon-
drocytes and tenocytes. TA is applied intra-articularly, to 
avoid postoperative bleeding following arthroplasty. We 
can conclude from our results that an intra-articular injec-
tion of TA can also be done in native joints. The effect on 
chondrocytes and tenocytes is comparable with iodine 
contrast media, which has been used for decades without 
clinically reported negative effects. HA does not appear 
to have any adverse effects in vitro.
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Fig. 5
live staining of chondrocytes. live cells are visible as green fluorescent cells 
and represented here in black. Normal saline serves as control.
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Fig. 6
live staining of tenocytes. live cells are visible as green fluorescent cells and 
represented here in black. Normal saline serves as control.
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